Search Results - Lilli Podola

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    A phase 1 trial extension to assess immunologic efficacy and safety of prime-boost vaccination with VXM01, an oral T cell vaccine against VEGFR2, in patients with advanced pancreatic cancer

    A phase 1 trial extension to assess immunologic efficacy and safety of prime-boost vaccination with VXM01, an oral T cell vaccine against VEGFR2, in patients with advanced pancreat... by Friedrich H. Schmitz-Winnenthal, Nicolas Hohmann, Thomas Schmidt, Lilli Podola, Tobias Friedrich, Heinz Lubenau, Marco Springer, Sébastien Wieckowski, Klaus M. Breiner, Gerd Mikus, Markus W. Büchler, Anne-Valérie Keller, Ruhan Koc, Christoph Springfeld, Phillip Knebel, Mariana Bucur, Lars Grenacher, Walter E. Haefeli, Philipp Beckhove

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Anti-angiogenic activity of VXM01, an oral T-cell vaccine against VEGF receptor 2, in patients with advanced pancreatic cancer: A randomized, placebo-controlled, phase 1 trial

    Anti-angiogenic activity of VXM01, an oral T-cell vaccine against VEGF receptor 2, in patients with advanced pancreatic cancer: A randomized, placebo-controlled, phase 1 trial by Friedrich H. Schmitz-Winnenthal, Nicolas Hohmann, Andreas G. Niethammer, Tobias Friedrich, Heinz Lubenau, Marco Springer, Klaus M. Breiner, Gerd Mikus, Jürgen Weitz, Alexis Ulrich, Markus W. Buechler, Frank Pianka, Ulla Klaiber, Markus K. Diener, Christine Leowardi, Simon Schimmack, Leila Sisic, Anne-Valérie Keller, Ruhan Koc, Christoph Springfeld, Philipp Knebel, Thomas Schmidt, Yingzi Ge, Mariana Bucur, Slava Stamova, Lilli Podola, Walter E. Haefeli, Lars Grenacher, Philipp Beckhove

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: